Persistent erythema multiforme treated with thalidomide
Journal
American Journal of Clinical Dermatology
Journal Volume
9
Journal Issue
2
Pages
123-127
Date Issued
2008
Author(s)
Abstract
Erythema multiforme is a common self-limited disorder that predominantly affects younger individuals. It is characterized by typical iris or target lesions on the skin and mucous membranes. Three clinical subgroups of erythema multiforme have been identified: classical erythema multiforme, recurrent erythema multiforme, and persistent erythema multiforme. By definition, persistent erythema multiforme is characterized by the occurrence of continuous typical and atypical lesions without interruption. We report a 15-year-old boy who developed persistent erythema multiforme for 6 months and responded to treatment with thalidomide. ? 2008 Adis Data Information BV. All rights reserved.
SDGs
Other Subjects
corticosteroid; thalidomide; valaciclovir; adolescent; article; case report; clinical feature; drug dose reduction; Epstein Barr virus; erythema multiforme; Hepatitis C virus; Herpes simplex virus; human; male; Mycoplasma pneumoniae; pathogenesis; physical examination; priority journal; treatment response; Adolescent; Erythema Multiforme; Humans; Immunosuppressive Agents; Male; Skin; Thalidomide
Type
journal article